Access 2.8M+ Filings Sign Up Free
Swedish Orphan Biovitrum Logo

Swedish Orphan Biovitrum | SOBI - Profile, Filings, Stock Info & Investor Relations Data

Swedish Orphan Biovitrum | SOBI
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
2010
Swedish Orphan Biovitrum (SOBI)

Company Profile

About Swedish Orphan Biovitrum

At Sobi, we are transforming life for people with rare diseases. As an international biopharmaceutical company, we provide access to innovative treatments in the areas of haematology, immunology and specialty care.

- Two therapeutic areas – Haematology and Immunology – and a portfolio of products within Specialty Care
- Our extended half-life factor replacement treatments are the most prescribed treatments for haemophilia - A and B respectively in several markets
- A strong portfolio of on-market products, and an extensive portfolio of pre-market assets
- An international biopharmaceutical company covering the entire value chain
- We put our focus where we can have the greatest impact, in late-stage research and development, and in patient access and commercialisation

Employees

1,509

Market Presence

Worldwide

Headquarters

Tomtebodavagen 23A
112 76, Stockholm
Sweden

Company Video

Video thumbnail
Click to load video from YouTube

Swedish Orphan Biovitrum (SOBI)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Get Notified About Swedish Orphan Biovitrum's New Filings

Receive email alerts when new documents are published.

You can unsubscribe at any time.

Swedish Orphan Biovitrum (SOBI)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↓
Katy Mazibuko (Other)
Sell SEK 480,000.00 SEK 320.00 30.08.24
↓
Katy Mazibuko (Other)
Sell SEK 86,012.75 SEK 319.75 30.08.24
↑
Sara Karlsson (Other)
Buy SEK 23,391.79 SEK 271.99 12.08.24
↑
Mahmood Ladha (Other)
Buy SEK 12,360,406.05 SEK 146.13 25.07.24
↓
Mahmood Ladha (Other)
Sell SEK 24,614,235.00 SEK 291.00 23.07.24
◆
Christin Wesström (Other)
Other SEK 0.00 SEK 0.00 10.06.24
↑
Guido Oelkers (Other)
Buy SEK 23,965,061.00 SEK 204.25 03.06.24
↓
Guido Oelkers (Other)
Sell SEK 32,090,302.00 SEK 273.50 30.05.24
↑
Henrik Stenqvist (Other)
Buy SEK 14,815,069.50 SEK 204.25 15.05.24
↓
Henrik Stenqvist (Other)
Sell SEK 20,766,484.20 SEK 286.30 13.05.24

Swedish Orphan Biovitrum (SOBI)
Stock & Investor Information

ISINs

Showing 5 of 52
SE0000872095
SE0001713256
SE0002729574
SE0013885308
SE0013885316

LEI

549300124Y3MQI87PT35

Stock Exchange Listings

Nasdaq Stockholm

Stock Index Memberships

STOXX Europe 600

Industry Classification

Sector
Health Care
Industry
Biotechnology